Phase 1 Trigeminal Neuralgia Clinical Trials
2 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–2 of 2 trials
Recruiting
Phase 1
Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells Exosomes for Trigeminal Neuralgia
Peripheral NeuropathyTrigeminal Neuralgia
The Foundation for Orthopaedics and Regenerative Medicine20 enrolled1 locationNCT05152368
Recruiting
Phase 1
Deep Brain Stimulation for Refractory Trigeminal Neuralgia with a Pontine Lesion
Trigeminal Neuralgia
Université de Sherbrooke6 enrolled1 locationNCT05451251